While many animal studies suggest that the upregulation of TMEM16A and NKCC1 could contribute to the increased vascular contractility and elevated blood pressure in hypertension as mentioned in the preceding sections, there is very little information concerning their possible involvement in the pathogenesis of hypertension in humans. This evidence concerns the gene SLC12A2 and hypertensive disorder.